Cargando…
SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis
BACKGROUND: Thyroid carcinoma (TC) is an increasingly common malignancy of endocrine organs, and its most frequently encountered histotype is papillary thyroid cancer (PTC). Identifying new potential gene alterations is important for completely elucidating the mechanism of PTC initiation and progres...
Autores principales: | Zhou, Xiaofen, Lin, Lizhi, Qi, Yufeng, Xu, Min, Xu, Qiding, Wang, Yinghao, Qu, Jinmiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365581/ https://www.ncbi.nlm.nih.gov/pubmed/35968508 http://dx.doi.org/10.1155/2022/2562595 |
Ejemplares similares
-
SPTBN2, a New Biomarker of Lung Adenocarcinoma
por: Wu, Chunli, et al.
Publicado: (2021) -
Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
por: Wen, Jialiang, et al.
Publicado: (2020) -
Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer
por: Lin, Lizhi, et al.
Publicado: (2020) -
Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome
por: Cousin, Margot A., et al.
Publicado: (2021) -
Mettl1-mediated internal m(7)G methylation of Sptbn2 mRNA elicits neurogenesis and anti-alzheimer’s disease
por: Li, Qingfeng, et al.
Publicado: (2023)